by John A. Jenkins | Apr 30, 2024 | FOIA, Hedge Funds, Stock Market
FOIAengine: Traders Had an Inside Track on the CPI. Journalists Used FOIA to Expose It. Today’s story is about the Bureau of Labor Statistics, which calculates the all-important Consumer Price Index. It’s also a cautionary tale about how a select few on Wall Street...
by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market
FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets. One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk. The other – Aaron Greenspan –...
by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas. That’s according to...
by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market
FOIAengine: Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...